Handelsavisen
prelaunch
Companies Healthcare ABAT.BO
AB
ABAT.BO BSE (India) Healthcare Facilities & Services

Abat.Bo

$10,39
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
1,3 %
ROE
0,4 %
Net margin
5,1 %
Debt / equity
0,06
Beta
52w range
Volume
Day range
Prev close
$2,68
Open
Next earnings
2026-08-09
Ex-dividend
TR 1Y
About

ABAT.BO operates in the Healthcare Facilities & Services industry, providing pharmaceutical products and related services.

Business. AMERICAN BATTERY TECHNOLOGY Co (ABAT) is a metals and mining company engaged in the production and sale of battery materials. The firm operates within the Basic Materials sector, specifically focusing on mineral resources. It is headquartered in the United States and is primarily listed on the Nasdaq stock exchange. The company does not disclose specific operating segments or geographic revenue breakdowns in the provided data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsFY 2026 earnings (expected)2026-08-09 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
State Street Investment Management (US)
largest disclosed fund holder
Profitability
0,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ABAT.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ABAT.BO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsFY 2026 earnings (expected)2026-08-09 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    AMERICAN BATTERY TECHNOLOGY Co (ABAT) is a metals and mining company engaged in the production and sale of battery materials. The firm operates within the Basic Materials sector, specifically focusing on mineral resources. It is headquartered in the United States and is primarily listed on the Nasdaq stock exchange. The company does not disclose specific operating segments or geographic revenue breakdowns in the provided data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    ABAT.BO maintains a conservative capital structure with a debt-to-equity ratio of 0.06, significantly below the industry median, indicating a low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.66, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its liquidity risk.

    In terms of profitability, ABAT.BO's return on equity (ROE) is 0.0043 and return on assets (ROA) is 0.0035, both of which are below the industry median for Healthcare Facilities & Services. This suggests that the company is underperforming relative to its peers in generating returns for shareholders and utilizing its assets efficiently.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher operational and market risks if the segment faces challenges.

    ABAT.BO's growth trajectory is not clearly defined in the available data, as there are no specific revenue growth projections or historical growth rates provided. The company's capital expenditure is minimal, with a negative value of -385,460 INR, indicating that it is not investing heavily in new projects or infrastructure.

    The risk assessment for ABAT.BO highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to meet short-term obligations. However, the dilution risk is low, as there is no indication of significant share issuance or dilution potential.

    Recent events and filings for ABAT.BO are not detailed in the available data, making it difficult to assess any recent developments that could impact the company's financial performance or strategic direction.

    Key takeaways
    • ABAT.BO has a conservative capital structure with a low debt-to-equity ratio of 0.06.
    • The company's ROE and ROA are below the industry median, indicating underperformance in profitability.
    • ABAT.BO's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
    • The company's liquidity risk is medium, and its dilution risk is low.
    • ABAT.BO's growth trajectory is not clearly defined, and there is no significant capital expenditure.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $10,39
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.64B
    Net cash
    -$89.5M
    Current ratio
    2.7
    Debt / equity
    0.1
    ROA
    0.4%
    ROE
    0.4%
    Cash conversion
    241.0%
    CapEx / revenue
    -0.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin1,3 %Below median
    Net Margin5,1 %Above median
    ROE0,4 %Below median
    Capex / Rev-0,3 %Above P75
    D/E0,06Above P75
    Cash Conv2,41Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 3 460 931 sh2 transactions2 insiders
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Warrants → Common StockAcquired 2 367 656 @ $0,99purchase · 2026-06-05
    • Wu StevenChief Operating Officer · Warrants → Common StockAcquired 1 093 275 @ $1,07purchase · 2026-06-05

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • ABAT.BO Market data — financials · 2026-05-27

    Ownership & reference

    Top holders

    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$28M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$5M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$8M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$3M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$2M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$25M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$1M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$1M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$2M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$0M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$0M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$1M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling0 buys · 3 sellsnet -$628K6 insiders · last 365d
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 7 780 @ $2,50$19K · 2026-07-22
    • JOLCOVER SCOTTFormer Chief Resource Officer · Common StockOther 8 334 · 2026-07-20
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 20 834 · 2026-07-20
    • Lowery Elizabeth AnnDirector · Common StockOther 10 949 · 2026-07-06
    • Lee Susan YDirector · Common StockOther 10 949 · 2026-07-06
    • Fezell Donald Richard JRDirector · Common StockOther 22 629 · 2026-07-06
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 21 242 @ $2,88$61K · 2026-07-02
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 24 695 @ $2,82$70K · 2026-07-01
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 54 728 · 2026-07-01
    • JOLCOVER SCOTTFormer Chief Resource Officer · Common StockOther 21 569 · 2026-07-01
    • JOLCOVER SCOTTFormer Chief Resource Officer · Common StockOther 9 134 · 2026-06-30
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 10 937 · 2026-06-30
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 54 971 · 2026-06-30
    • Wu StevenChief Operating Officer · Common StockOther 55 680 @ $3,18$177K · 2026-06-17
    • Wu StevenChief Operating Officer · Common StockOther 102 598 · 2026-06-16
    • Wu StevenChief Operating Officer · Common StockSold 115 480 @ $3,56$411K · 2026-06-15
    • Wu StevenChief Operating Officer · Common StockOther 107 760 @ $3,49$376K · 2026-06-08
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 138 270 @ $3,49$483K · 2026-06-08
    • Wu StevenChief Operating Officer · Common StockOther 203 700 · 2026-06-04
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 337 955 · 2026-06-04
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 9 323 @ $3,77$35K · 2026-06-02
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 29 674 @ $0,71$21K · 2026-06-02
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 33 384 · 2026-06-01
    • Melsert Ryan MitchellDirector, Chief Executive Officer · Common StockOther 4 962 @ $3,49$17K · 2026-04-22
    • JOLCOVER SCOTTFormer Chief Resource Officer · Common StockOther 8 333 · 2026-04-20

    Short positioning

    21.4Mshares short-4.6% vs prior
    6.39days to cover
    42.4%short of daily vol
    3.8Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ABAT.BOCanonical
    BSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -75.3%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 132.5%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 68.5%Derived (calculated)
    • Current ratio (FY 2025-12-31): 14.88xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.04xDerived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 39.7%Derived (calculated)
    • Shares outstanding (annual): 131.03MSEC XBRL filing
    • Current liabilities (annual): USD 4.24MSEC XBRL filing
    • Total assets (annual): USD 123.34MSEC XBRL filing
    • Shareholders' equity (annual): USD 118.98MSEC XBRL filing
    • Current assets (annual): USD 63.05MSEC XBRL filing
    • Cash & equivalents (annual): USD 47.9MSEC XBRL filing
    • Total liabilities (annual): USD 4.36MSEC XBRL filing
    • Operating income (YoY) (2025-06-30 vs 2024-06-30): 12.0%Derived (calculated)
    • Gross profit (YoY) (2025-06-30 vs 2024-06-30): -257.1%Derived (calculated)
    • Operating cash flow (YoY) (2025-06-30 vs 2024-06-30): -72.7%Derived (calculated)
    • Cost of revenue (YoY) (2025-06-30 vs 2024-06-30): 349.8%Derived (calculated)
    • Net income (YoY) (2025-06-30 vs 2024-06-30): 10.9%Derived (calculated)
    • EPS (basic) (YoY) (2025-06-30 vs 2024-06-30): 43.1%Derived (calculated)
    • Revenue (YoY) (2025-06-30 vs 2024-06-30): 1,149.0%Derived (calculated)
    • Gross margin (FY 2025-06-30): -246.5%Derived (calculated)
    • Net margin (FY 2025-06-30): -1,090.0%Derived (calculated)
    • EPS (diluted) (YoY) (2025-06-30 vs 2024-06-30): 43.1%Derived (calculated)
    • R&D expense (YoY) (2025-06-30 vs 2024-06-30): -40.9%Derived (calculated)
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-09EVENTUpcomingFY 2026 earnings (expected) estimated date
    2026-07-22INSIDERMelsert Ryan Mitchell transacted 7.8k sh — Director, Chief Executive Officer ~$19k
    2026-07-20INSIDERJOLCOVER SCOTT transacted 8.3k sh — Former Chief Resource Officer
    2026-07-20INSIDERMelsert Ryan Mitchell transacted 20.8k sh — Director, Chief Executive Officer
    2026-07-11 04:42 UTCFILINGMaterial 8-K
    2026-07-06INSIDERLowery Elizabeth Ann transacted 10.9k sh — Director
    2026-07-06INSIDERLee Susan Y transacted 10.9k sh — Director
    2026-07-06INSIDERFezell Donald Richard JR transacted 22.6k sh — Director
    2026-07-02INSIDERMelsert Ryan Mitchell transacted 21.2k sh — Director, Chief Executive Officer ~$61k
    2026-07-01INSIDERJOLCOVER SCOTT transacted 21.6k sh — Former Chief Resource Officer
    2026-07-01INSIDERMelsert Ryan Mitchell transacted 24.7k sh — Director, Chief Executive Officer ~$70k
    2026-07-01INSIDERMelsert Ryan Mitchell transacted 54.7k sh — Director, Chief Executive Officer
    2026-06-30INSIDERMelsert Ryan Mitchell transacted 10.9k sh — Director, Chief Executive Officer
    2026-06-30INSIDERJOLCOVER SCOTT transacted 9.1k sh — Former Chief Resource Officer
    2026-06-30INSIDERMelsert Ryan Mitchell transacted 55.0k sh — Director, Chief Executive Officer
    2026-06-17 00:00 UTCINSIDER12 insider transactions — 2026-06 · net sell $1.5M 2 derivative
    2026-06-17INSIDERWu Steven transacted 55.7k sh — Chief Operating Officer ~$177k
    2026-06-16INSIDERWu Steven transacted 102.6k sh — Chief Operating Officer
    2026-06-15INSIDERWu Steven sold 115.5k sh — Chief Operating Officer ~$411k
    2026-06-08FILING8-K filing →
    2026-06-08INSIDERWu Steven transacted 107.8k sh — Chief Operating Officer ~$376k
    2026-06-08INSIDERMelsert Ryan Mitchell transacted 138.3k sh — Director, Chief Executive Officer ~$483k
    2026-06-05INSIDERMelsert Ryan Mitchell acquired 2.37M sh Warrants — Director, Chief Executive Officer
    2026-06-05INSIDERWu Steven acquired 1.09M sh Warrants — Chief Operating Officer
    2026-06-04INSIDERWu Steven transacted 203.7k sh — Chief Operating Officer
    2026-06-04INSIDERMelsert Ryan Mitchell transacted 338.0k sh — Director, Chief Executive Officer
    2026-06-03FILING8-K filing →
    2026-06-02INSIDERMelsert Ryan Mitchell transacted 9.3k sh — Director, Chief Executive Officer ~$35k
    2026-06-02INSIDERMelsert Ryan Mitchell transacted 29.7k sh — Director, Chief Executive Officer ~$21k
    2026-06-01INSIDERMelsert Ryan Mitchell transacted 33.4k sh — Director, Chief Executive Officer
    2026-05-12FILING8-K filing →
    2026-05-11FILING10-Q filing →
    2026-04-22 00:00 UTCINSIDER11 insider transactions — 2026-04
    2026-04-22INSIDERMelsert Ryan Mitchell transacted 5.0k sh — Director, Chief Executive Officer ~$17k
    2026-04-20INSIDERJOLCOVER SCOTT transacted 8.3k sh — Former Chief Resource Officer
    2026-03-17 00:00 UTCINSIDER5 insider transactions — 2026-03 · net sell $119k
    2026-02-09FILING8-K filing →
    2026-02-05FILING10-Q filing →
    2026-01-29FILING8-K filing →
    2026-01-21 00:00 UTCINSIDER13 insider transactions — 2026-01 · net sell $136k
    Showing the 40 most recent of 46 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage